Gastro-resistant Matrix Using Swellable Polymers

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing gastro-resistant pharmaceutical forms require lengthy film coating processes, which are limited to solid dosage forms and struggle with achieving delayed release in multilayered tablets without affecting other layers, and are inefficient for active ingredients with different release kinetics.

Innovation Solution

A solid gastro-resistant pharmaceutical form is created using a mixture of three hydrophilic polymers: a swellable pH-independent polymer, a swellable polymer insoluble at pH lower than 4.0 and soluble at higher pH, and an oligomer that forms a soluble complex with the active ingredient, forming a transient gelled barrier that delays release until intestinal pH is reached, eliminating the need for film coating.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If film coating techniques are used to create gastro-resistant dosage forms, then the active ingredient is protected from gastric environment, but the manufacturing process becomes particularly long and complex

Engineering Contradiction:
Improvegastro-resistanceVSAvoidmanufacturing time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The invention extracts and eliminates the film coating step from the manufacturing process. Instead of coating the core with gastro-resistant film, the gastro-resistant matrix is directly compressed from a powder mixture containing swellable polymers and pH-dependent polymers, achieving gastro-resistance without the time-consuming coating process

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The gastro-resistant matrix is segmented into multiple functional components: swellable polymers (first and second polymers) that provide structural framework and pH-dependent polymer (third polymer) that provides the gastro-resistant mechanism. This segmentation allows each component to perform its specific function efficiently

Inventive Principle:
Principle #1Segmentation

2Reliability

If film coating is applied to achieve delayed release in multilayered tablets, then one layer gains gastro-resistance, but all other layers are also coated and affected

Engineering Contradiction:
Improvedelayed release controlVSAvoidselective layer protection
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The invention applies local quality by incorporating the gastro-resistant matrix composition specifically into the layer requiring delayed release, while other layers can have different compositions and release characteristics. Each layer can be independently formulated with the appropriate polymer mixture to achieve its specific release profile without affecting other layers

Inventive Principle:
Principle #3Local quality

3Reliability

If film coating techniques are used, then gastro-protection is achieved, but the process is inefficient for active ingredients with different release kinetics

Engineering Contradiction:
Improvegastro-protectionVSAvoidmanufacturing efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The gastro-resistant matrix composition based on swellable and pH-dependent polymers is a universal solution that can be applied to any active ingredient requiring gastro-protection or delayed release, regardless of its specific release kinetics requirements. The polymer composition can be adjusted to accommodate different release profiles while maintaining the same fundamental mechanism

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach efficiently delays the release of active ingredients through the gastric tract, providing gastro-resistance or gastro-protection without the need for film coating, and allows for single gastro-resistant layers in multilayered tablets, simplifying the manufacturing process and ensuring controlled release at intestinal pH.

Implementation Method 1

the first polymer is swellable and pH-independent

Methodology Applied
Scientific EffectSwelling:

Implementation Method 2

they form together a strong transient barrier of gelled polymer

Methodology Applied
Scientific EffectGel formation: Gel

Implementation Method 3

the second polymer is swellable, insoluble at pH lower than 4.0 and soluble at pH higher than 4.0

Methodology Applied
Scientific EffectpH-dependent solubility:

Implementation Method 4

the third polymer is an oligomer able to make a soluble complex with the active ingredient

Methodology Applied
Scientific EffectComplex formation:

Implementation Method 5

The gelled barrier reduces the diffusion of the active ingredient when the dosage form containing these polymers is immersed in an acid solution

Methodology Applied
Scientific EffectDiffusion barrier: Diffusion

Data Source

PatentEP2874611B1Gastro-resistant delayed release pharmaceutical form
Publication Date: 2016.09.14 RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA
  • EP2874611B1 patent drawingFigure 1
  • EP2874611B1 patent drawingFigure 2

AI summary

A solid gastro-resistant delayed release pharmaceutical form obtained without using gastro-resistant film coating is described.